endotron inc said becaus it decis discontinu develop health care product reorgan under chapter and establish adequ allow for uncollect receiv expect establish reserv total about mln dlrs march second quarter compani said plan seek buyer for health care technolog includ proprietari right hepat vaccin and technolog relat lak cell cancer immunotherapi reuter 